![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 20, 12548-12554, May 15, 1998
,
,
,
,
From the Excitatory neurotransmitters such as glutamate
are required for the normal functioning of the central nervous system
but can trigger excitotoxic neuronal injury if allowed to accumulate to abnormally high levels. Their extracellular levels are controlled primarily by transmitter uptake into astrocytes. Here, we demonstrate that the amyloid protein precursor may participate in the regulation of
this important process. The amyloid protein precursor has been well
conserved through evolution, and a number of studies indicate that it
may function as an endogenous excitoprotectant. However, the mechanisms
underlying this neuroprotective capacity remain largely unknown. At
moderate levels of expression, human amyloid protein precursors
increased glutamate/aspartate uptake in brains of transgenic mice, with
the 751-amino acid isoform showing greater potency than the 695-amino
acid isoform. Cerebral glutamate/aspartate transporter protein levels
were higher in transgenic mice than in non-transgenic controls, whereas
transporter mRNA levels were unchanged. Amyloid protein
precursor-dependent stimulation of aspartate uptake by
cultured primary astrocytes was associated with increases in protein
kinase A and C activity and could be blocked by inhibitors of these
kinases. The stimulation of astroglial excitatory amino acid transport
by amyloid protein precursors could protect the brain against
excitotoxicity and may play an important role in neurotransmission.
Departments of Neurosciences and Pathology,
University of California San Diego, La Jolla, California 92093-0624, the ¶ Gladstone Institute of Neurological Disease and Department
of Neurology, University of California San Francisco, San Francisco,
California 94141-9100 the
Sanders-Brown Research Center on Aging
and Department of Anatomy and Neurobiology, University of Kentucky,
Lexington, Kentucky 40536 and ** Neuroscience Program, University of
California, San Francisco, California 94141-9100
This article has been cited by other articles:
![]() |
B. C. Albensi, C. Igoechi, D. Janigro, and E. Ilkanich Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury? American Journal of Alzheimer's Disease and Other Dementias, September 1, 2004; 19(5): 269 - 274. [Abstract] [PDF] |
||||
![]() |
L. Mucke, E. Masliah, G.-Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation J. Neurosci., June 1, 2000; 20(11): 4050 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Hsia, E. Masliah, L. McConlogue, G.-Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R. C. Malenka, R. A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models PNAS, March 16, 1999; 96(6): 3228 - 3233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |